Ethtry Secratary

Igraine Plc – Holding(s) in Company PR Newswire Igraine plc (AQSE:KING), an investing company focused on breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors, has received 2 TR-1 Forms, which are reproduced without amendment below. TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR…

Igraine Plc – Final Results PR Newswire 30 June 2023 Igraine Plc AQSE: KING (“Igraine” or “the Company”) Audited Financial Statements for the Year Ended 31 December 2022 The full audited annual report can be found on the Company’s website https://igraineplc.com. REVIEW OF BUSINESS The Directors have been successful in…

Igraine Plc – Investment in Fixit Medical Ltd PR Newswire THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT  VIA A REGULATORY INFORMATION SERVICE (“RIS”), THIS…

Igraine Plc – Result of AGM PR Newswire 11th November 2022 Igraine plc AQSE: KING (“Igraine” or “the Company”) Result of Annual General Meeting The Company is pleased to announce that, at its Annual General Meeting held on Thursday, 10 November 2022 at 10:30 a.m., all resolutions were duly passed.…

Igraine Plc – Investee Update – AZD1656 PR Newswire 9th November 2022 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT  VIA A REGULATORY INFORMATION SERVICE…

Igraine Plc – Notice of AGM and Share Purchase PR Newswire 13 October 2022 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT  VIA A REGULATORY…

Igraine Plc – ARCADIA trial – Lancet eClinicalMedicine publication PR Newswire 19 August 2022 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT  VIA A REGULATORY…